IL-13 and IL-18 play complex and diverse roles in the development of cancer, involving not only tumor growth, dissemination, and immune evasion mechanisms but also providing new targets for cancer prognostic biomarkers and therapeutic interventions (50–52). The gene discussed is IL13; the disease is neoplasm.